慢性前列腺炎患者前列腺液与尿道分泌物支原体感染情况分析

Analysis of mycoplasma infection situation in prostatic serection and urinary tract secretion of patients with chronic prostatitis

目的探讨支原体在慢性前列腺炎患者的前列腺液与尿道分泌物中的感染情况以提高慢性前列腺炎的诊治水平。方法选取笔者所在医院2011年1～12月收治的329例慢性前列腺炎患者,随机分为实验组(165例)与对照组(164例),其中对照组采集前列腺按摩液送检培养支原体,实验组采集尿道分泌物送检培养支原体,培养24h和48h后观察培养结果。结果 329例慢性前列腺炎患者两组标本结果:实验组支原体培养呈阳性占该组患者的47.27%远高于对照组24.39%,两组比较差异有统计学意义(P<0.05)。两组间UU阳性率实验组41.81%远高于对照组21.94%,差异有统计学意义(P<0.05)。而对照组与实验组的MH以及MH+UU的阳性率与弱阳性性率结果差异无统计学意义(P>0.05)。结论本研究表明采取规范的标本采集方法和选择合适的标本采集部位可提高支原体阳性检出率,因而在临床实践中对于慢性前列腺炎患者如检测支原体可优先考虑选择取尿道分泌物可提高对支原体的临床检出率。

Objective To investigate the situation of mycoplasma infection in the prostatic serection and urinary tract secretion of patients with CP in order to improve the diagnosis and treatment level of CP. Methods 329 patients with CP admitted to and treated in our hospital from January 2011 to December 2011 were selected and randomly divided into the experimental group（165 patients）and the control group（164 patients）. The EPS of the control group was collected to culture mycoplasma while the urinary tract serection of the experimental group was collected to culture mycoplasma. The culture results were observed 24 hours and 48 hours after culturing. Results The specimen results of the 329 patients with CP were as follows：in the experimental group,the positive rate of mycoplasma was 47.27%,significantly higher than the 24.39% in the control group,with statistically significant difference（P 〈 0.05）. Regrading to the UU positive rate,the 41.81% in the experimental group was far higher than the 21.94% in the control group,with significant difference（P ~ 0.05）. As for the positive rates and weak positive rates of MH and MH＋UU,the control group and the experimental group were not significantly different（P ~ 0.05）. Conclusion This study shows that standardized specimen collection methods and proper specimen collection locations can improve the positive detection rate of mycoplasma,thus in clinial practice,urinary tract secretion can be considered the priority in detecting mycoplasma of patients with CP in order to improve the clinical detection rate of mycoplasma.